• Title/Summary/Keyword: hyperlipidemia

Search Result 939, Processing Time 0.031 seconds

Effects of Iksugangjiryung on Hyperlipidemia in Rats (익수강지령(益壽降脂靈)이 흰쥐의 고지혈증 병태에 미치는 영향)

  • No, Hyun-Suk;Kim, Jeung-Beum
    • Journal of Physiology & Pathology in Korean Medicine
    • /
    • v.22 no.5
    • /
    • pp.1283-1292
    • /
    • 2008
  • This study was designed to investigate the hyperlipidemia-healing effect of water extract from Iksukangjiryung, it was performed on the hyperlipidemia of rats induced by Triton WR-1339 and high cholesterol diet. We prepared two types of hyperlipidemia model in rats induced by Triton WR-1339 and high cholesterol diet. The amount of total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride, lipid peroxide, glutathione and the activity of superoxide dismutase(SOD) were measured. The water extract from Iksukangjiryung showed significant decreasing effects on total cholesterol, LDL- cholesterol, triglyceride, lipid peroxide in the both model. And it showed significant increasing effects on the activity of SOD in both model and amount of glutathione in Triton WR-1339 model. These results suggest that water extract from Iksukangjiryung has healing efficacy on hyperlipidemia induced by Triton WR-1339 and high cholesterol diet.

Preventive Effects of Nokyongdaebotang on Hyperlipidemia Rats (녹용대보탕(鹿茸大補湯) 투여에 의한 흰쥐의 고지혈증(高脂血證) 예방(豫防)에 관한 실험 연구)

  • Lee Sang-Woon;Jeong Chan-Gil;Kuim Kwang-Ho;Soh Kyung-Sun
    • Journal of Society of Preventive Korean Medicine
    • /
    • v.7 no.2
    • /
    • pp.107-119
    • /
    • 2003
  • In order to study the preventive effects of hyperlipidemia depending on endogenous and exogenous methods of induction, after observing what happens when Nokyongdaebotang, a strengthening up treatment is orally administrated into the ways that cause hyperlipidemia either by the exogenous hyperlipidemia condition model method, which is the way where you orally administrate the cholesterol that was dissolved in olive oil, or the endogenous hyperlipidemia model method, where it uses the injecting the Triton WR-1339 vein method, or to the already inducted white rats, the following conclusions could be drawn. 1. The endogenous induction method, cholesterol diet, helps preventing Total Cholesterol, TG, and LDL-Cholesterol, Free Fatty Acid, Phospholipid's augmentation within the blood in the white rats that is being induced or just inducted with hyperlipidemia 2. The exogenous induction method, Triton WR injection, helps preventing Total Cholesterol, TG, and LDL-Cholesterol, Free Fatty Acid, Phospholipid's augmentation within the blood in the white rats that is being induced or just inducted with hyperlipidemia 3. The HDL-Cholesterol did not increase in regard. This is considered to be because when the geological features the HDL-Cholesterol increases proportionally. In deference to the above results, Nokyongdaebotang, which strengthens the vitality, showed that it helps prevent white rats that is being induced or just inducted with hyperlipidemia no matter whether it is endogenous or exogenous.

  • PDF

Study on the Effect of CSDDT on Hyperlipidemia (정신도담탕(精神導痰湯)이 식이성(食餌性) 고지혈증(高脂血症) 동물(動物) 병태(病態)에 미치는 영향(影響))

  • Lee, Won-Gu;Lee, Yong-Gu;Namgung, Uk;Kim, Dong-Hee
    • Journal of Haehwa Medicine
    • /
    • v.13 no.2
    • /
    • pp.109-122
    • /
    • 2004
  • As a long-term goal for the development of new prescriptions for hyperlipidemia, Cheungsimdodamtang(CSDDT) was examined in the present study using a rat model in which the hyperlipidemia was induced. The major parameters related to lipid metabolism were investigated and the key findings are summarized below. 1. CSDDT-treated animal group showed only a 4.5% body weight increase compared to normal animal group whereas hyper- lipidemia-induced control group increased body weight by 13.6% compared to normal animals. 2. CSDDT-induced animal group showed a significant decrease in cholesterol levels beginning one week after CSDDT treatment, compared to hyperlipidemia-induced control group. 3. Total cholesterol levels in CSDDT-treated animal group were significantly decreased compared to the hyperlipidemia-induced control group. 4. Glucose levels in CSDDT-treated animal group were significantly decreased compared to the hyperlipidemia-induced control group. 5. Triglyceride levels in CSDDT-treated animal group were significantly decreased compared to the hyperlipidemia-induced control group. 6. SGOT and SGPT levels in CSDDT-treated animal group were significantly decreased compared to the hyperlipidemia-induced control group. 7. HDL-cholesterol levels were significantly increased in CSDDT -treated animal group compared to the hypeiIipidemia-induced control group. 8. LDL-cholesterol levels were significantly decreased in CSDDT-treated animal group compared to the hyperlipidemia-induced control group.

  • PDF

The comparative study between hyperlipidemia and disease of adult people, which belong to the people who came to Daejon Oriental hospital for the examination of C.V.A (중풍조기검진(中風早期檢診)을 통한 고지혈증(高脂血症)과 성인병(成人病)에 대한 비교연구(比較硏究))

  • Lee, Gi-Tae;Kim, Yun-Sik;Seol, In-Chan
    • Journal of Haehwa Medicine
    • /
    • v.11 no.1
    • /
    • pp.85-90
    • /
    • 2002
  • From June 1th to December 31th 2001, the study was carried out 285 person who came to the Daejon oriental hospital for the examination of CVA. The result was as follows : 1. Hyperlipidemia patient is 41%, 50's is the highest. 2. In the case of Hyperlipidemia patient, Taeyum type is 49%, Soyang type is 36% and Soyum type is 15%. but in the Control group Taeyum type is 36%, Soyang type is 44% and Soyum type is 20%. 3. In the case of Abnormal EKG, Hyperlipidemia group is 34%, Control group is 32%. 4. In the case of Liver disease, Hyperlipidemia group is 17%, Control group is 9%. 5. In the case of Diabet mellitus, Hyperlipidemia group is 30%, Control group is 7%. 6. In the case of Hypertension, Hyperlipidemia group is 50%, Control group is 42%.

  • PDF

Effects of He-Ne Intravascular Laser Irradiation on Hyperlipidemia (He-Ne 레이저 혈관내 조사(ILIB)가 고지혈증에 미치는 영향에 대한 임상보고)

  • Jang, In-Soo;Kang, Shin-Hwa;Kang, Hyon-Chul
    • The Journal of Internal Korean Medicine
    • /
    • v.21 no.4
    • /
    • pp.549-554
    • /
    • 2000
  • Purpose : Intravascular Laser Irradiation on Blood(ILlB) therapy has been usedto various circulatory diseases recently. In this study, we sought to find out the effects of ILIB on hyperlipidemia . Material and Methods : In this study of 163 patients with hyperlipidemia , we observed change of total cholesterol and triglyceride in serum after ILIB therapy. Results and Conclusion : In patients with hyperlipidemia , total cholesterol mean values decreased from $240.04{\pm}56.23$mg/dL to $214.90{\pm}45.84$mg/dL and triglyceride mean values decreased from $304.98{\pm}134.37$mg/dL to $244.05{\pm}120.46$mg/dL, after ILIB thetapy. We evaluated that ILIB therapy reduced total cholesterol and triglyceride (p<0.001) in patients with hyperlipidemia and IUB therapy is more effective to patients with hyperlipidemia than normal(p<0.001).

  • PDF

The Effects of Ssanggang-tang($Shu\bar{a}ngji\grave{a}ng-t\bar{a}ng$) on Rat with Induced Hyperlipidemia (쌍강탕(雙降湯)이 고(高)cholesterol 식이(食餌)로 유발(誘發)된 고지혈증(高脂血症) 백서(白鼠)에 미치는 영향(影響))

  • Lee, Jae-Hwi;Lim, Seung-Min;An, Joung-Jo;Jo, Hyun-Kyung;Kim, Yoon-Sik;Seol, In-Chan;Yoo, Ho-Rhyong
    • The Journal of Internal Korean Medicine
    • /
    • v.29 no.2
    • /
    • pp.432-442
    • /
    • 2008
  • Objective : Ssanggang-tang(SGT) is noted as an effective method to treat hyperlipidemia in China. The main purpose of this study was analysis of the effects of Ssanggang-tang(SGT) on rats induced with caused hyperlipidemia. Methods : We observed 3 experimental groups: normal, control, and SGT. Rats were provided a normal diet in the normal group, and the other groups were provided a hyperlipidemic diet to induce hyperlipidemia. After 2 weeks, SGT was treated in the SGT group. For 6 weeks, values related to hyperlipidemia were observed in the 3 experimental groups. Results : SGT decreased some values related to hyperlipidemia like total cholesterol, low density lipoprotein cholesterol(LDL cholesterol), triglyceride, acetocoenzyme A acetyltransferase(ACAT), and 3-hydroxy-3-methylglutaryl coenzyme A reductase(HMG-CoA reductase). However, it showed no effect on weight change or high density lipoprotein cholesterol(HDL cholesterol). Conclusion : These results suggest that SGT might be effective in treatment and prevention of hyperlipidemia.

  • PDF

Experimental study on the effects of Guibitanggamibang on blood pressure and hyperlipidemia (귀비탕가미방(歸脾湯加味方)이 고혈압(高血壓) 및 고지혈증(高脂血症)에 미치는 영향(影響))

  • Roh, Jin-Hwan;Moon, Sang-Kwan;Ko, Chang-Nam;Cho, Ki-Ho;Kim, Young-Suk;Bae, Hyung-Sup;Lee, Kyung-Sup
    • The Journal of Korean Medicine
    • /
    • v.18 no.2
    • /
    • pp.245-266
    • /
    • 1997
  • In order to study the effects of Guibitanggamibang on blood pressure and hyperlipidemia, experimental study were performed on hypertension in normal and SHR rats, and on hyperlipidemia induced by Triton WR-1339 in normal rats. Also the level of total cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol, phospholipid and transaminase(GOT, GPT) were measured. The results are summarized as follows: 1. After Guibitanggamibang was given to normal rats, the results showed that inhibitory effects on blood pressure and heart beat were not statistically significant. 2. After Guibitanggamibang was given to SHR rats, the results showed that inhibitory effects on blood pressure were statistically significant. 3. In the model of hyperlipidemia induced by 2% cholesterol food, Guibitanggarrubang had significantly-decreasing effects on total cholesterol, triglyceride, HDL-cholesterol, LDL-choleste rol, Transaminase(GOT, GPT) level in serum. 4. In the model of hyperlipidemia induced by Triton WR-1339, Guibitanggamibang had significantly-decreasing effects on total cholesterol, triglyceride, LDL-cholesterol, phospholipid, Transaminase(GOT, GPT) level in serum. 5. In the model of hyperlipidemia induced by Triton WR-1339, Guibitanggamibang had no significant effects on HDL-cholesterol level in serum. These results show that Guibitanggamibang(歸脾湯加味方) has significant inhibitory effects on blood pressure and hyperlipidemia and that it could be clinically applied for hypertension and hyperlipidemia.

  • PDF

Factors in Managing Hyperlipidemia in Middle-aged Adults (중년기성인의 고지혈증관리 요인)

  • Jeong In Lee
    • Journal of Industrial Convergence
    • /
    • v.22 no.1
    • /
    • pp.163-168
    • /
    • 2024
  • This study was attempted to identify factors for managing hyperlipidemia in middle-aged adults. The research method is a secondary analysis study analyzing the 2018 data from the Korean Medical Panel Survey. The subjects of the study were 622 adults aged between 40 and 65 who were diagnosed with hyperlipidemia. As a result of the study, it was found that there was a correlation between the level of education and the presence or absence of hyperlipidemia management (𝒳2= 7.285, p = .026), and that there was a correlation between the subject's subjective health status and the presence or absence of hyperlipidemia management (𝒳2= 7.295, p =.026). Middle age is a time when the physical aging process begins in earnest, and there is a high possibility of developing chronic diseases, and hyperlipidemia is an early disease that causes chronic diseases. Accordingly, active health management is necessary, and in particular, the development of differentiated programs for hyperlipidemia management tailored to the subject's education level and health status is required.

Effects of CPs (Combined Preparations) of Radix Salvia Miltiorrhiza, Radix Notoginseng, and Borneolum on Hyperlipidemia (CPs(단삼, 삼칠, 빙편 복합제)가 고지혈증에 미치는 영향)

  • 이건목;이길숭
    • The Journal of Korean Medicine
    • /
    • v.25 no.2
    • /
    • pp.22-32
    • /
    • 2004
  • Objectives: In order to determine the effect of CPs, experimental studies were performed in hyperlipidemia humans. The contents of serum total cholesterol, TG (triglyceride), LDL cholesterol, HDL cholesterol, AST/ALT and BUN/creatinine were measured. Methods: We made a comparative study of total cholesterol, TG (triglyceride), LDL cholesterol, HDL cholesterol, AST/ALT and BUN/creatinine during one month off and on for twenty patients with hyperlipidemia who visited Gunpo Oriental Medical Center of Wonkwang University from December 2002 to July 2003. Results: The following result were obtained: 1. The serum TG and total cholesterol of patients who took CPs for one month showed significant (p<0.01) decrease. 2. The serum HDL-cholesterol and LDL-cholesterol of patients who took CPs for one month showed significantly increase in HDL, and decrease in LDL (p<0.05). 3. The serum AST/ALT and BUN/creatinine of patients who took CPs for one month showed no significant effects. Conclusions: According to the results mentioned above, the effects of CPs on serum triglyceride and total cholesterol of hyperlipidemia patients were significantly confirmed for decreasing effects.

  • PDF

Antioxidant and Lipid-lowering Effects of Artemisia capillaris on a Rat Model of Hyperlipidemia

  • Jang, Woo-Seok;Kim, Yoon-Sik;Seol, In-Chan
    • The Journal of Korean Medicine
    • /
    • v.33 no.2
    • /
    • pp.11-24
    • /
    • 2012
  • Objectives: This study was designed to evaluate lipid-lowering and antioxidant effects of Artemisia capillaris(A. capillaris) using a model of hyperlipidemic rats induced by poloxamer-407. Methods: Rats were previously treated by A. capillaris water extract, and intraperitoneally injected by poloxamer-407 to induce hyperlipidemia. Parameters of serum lipid and oxidative stress biomarkers were determined. Results: 1. A. capillaris ameliorated the elevation of serum total cholesterol, triglyceride, LDL-cholesterol and MDA level. 2. A. capillaris ameliorated the reduction of serum TAC and SOD activities. 3. A. capillaris ameliorated the reduction of serum GSH and GSH-reductase level. Conclusions: According to these results, A. capillaris can be used to treat hyperlipidemia or as basis for making new drugs for treating hyperlipidemia in the future.